Objective The primary aim of this analysis was to prospectively assess the full economic costs associated with implementing Newborn Hearing Screening Programme (NHSP) based on a two-stage screen, transient evoked otoacoustic emissions followed, if there is no clear response, by automated auditory brainstem response. Economic data were also collected from the Infant Distraction Test Screening (IDTS) service performed by health visitors at around eight months of age, which was being phased out. A comparison of costs and outcomes associated with NHSP and IDTS was conducted. Design 20 NHSP sites were invited to provide detailed cost data on NHSP implementation and 14 of these sites were selected to provide costs on the IDTS service that was being supplanted. Results There was marked variability in the costs. Given the higher yield of NHSP sites, the average cost per case detected across NHSP sites (£31,410/case) was approximately half that of IDTS sites (£69,919/case). Including family costs, the average total cost per case of NHSP (£34,826/case) was almost a quarter of IDTS (£117,942/case). Conclusions Family costs and cost per case associated with NHSP are considerably less than that with IDTS. These findings support the policy of implementation of NHSP and the phasing out of the IDTS.
INTRODUCTION
C ongenital permanent bilateral hearing loss affects 1-3 children of every 1000 children born in the UK and most western countries. 1 Early identification and intervention of the condition has been shown to significantly improve the language outcomes and future academic and occupational prospects. 2 Newborn Hearing Screening Programme (NHSP) in England is based on electrophysiological methods: transient evoked otoacoustic emissions (TEOAE), followed by automated auditory brainstem response (AABR) if no clear response/s at TEOAE. The screening is universal and takes place very soon after birth, either in the maternity hospital or in the community. NHSP has been reported to have benefits over traditional infant screening approaches like the targeted newborn screening (TNS) and Infant Distraction Test Screen (IDTS). 1, 3 In case of TNS, only high-risk newborns (usually Neonatal Intensive Care Unit babies) are screened with electrophysiological methods such as AABR and TEOAE. IDTS, on the other hand, is performed universally at around eight months of age. It consists of localization responses to low-level sounds presented to child by a tester while child's attention is suitably manipulated by a second tester.
With NHSP, coverage exceeds 90% with a specificity of approximately 95% and sensitivity of over 90%. 1 NHSP can potentially reduce the average age at identifying deafness from around two years to below six months. 3, 4 In May 2000, based on this evidence, the Department of Health in England announced funding of the first 23 sites to implement a NHSP service and to phase out the existing IDTS.
Few data have been published on the costs of infant hearing screening strategies. Stevens et al. 5 undertook the most detailed study to date. Questionnaires were sent to a number of centres across England and Wales that were undertaking either TNS, NHSP or IDTS. Costs of both screen and follow-up work were estimated directly from staff time. They reported costs of TNS, NHSP and IDTS at £5,052, £13,881 and £19,826 (1994 prices), respectively, for a standardized district of 1000 live births. Davies et al. 2 calculated a cost per child detected of ranging from approximately £82,000 to £102,000 for IDTS and £14,000-£20,000 for NHSP. Although the cost per case suggests the superior cost effectiveness of NHSP over IDTS, the authors expressed caution in their over-interpretation. Their costs did not include those of service set-up, items of screening equipment, consumables, and non-direct staff costs. Furthermore, as economic data suitable for inclusion were available only from a selection of centres, the generalizability of their results was unclear.
This paper reports a cost analysis carried out within the first phase of the NHSP in England. The primary aim of this analysis was to prospectively assess the full economic costs associated with implementing NHSP. Economic data were also collected from the IDTS service, which was being phased out. A comparison of costs associated with NHSP and IDTS will be presented.
Although this analysis did not inform decision-making as the case for NHSP over IDTS had already been made by Davis et al., 2 it was important to consider whether costs of implementing NHSP were acceptable.
METHODS
A societal perspective to costs was taken and included both health care and family costs. Categories of health care costs included: staffing; equipment; overheads; staff training and travel; and audiology costs. Long-term costs were not included.
Ethical approval was obtained via the North West Multicentre Research Ethics Committee (MREC 01/8/49, 25 June 2001) and the Local Research Ethics Committees.
Data source
The first phase of implementation of NHSP covered 23 sites across England. This represents an annual birth cohort of about 120,000. Implementation of NHSP in the first wave sites began in January 2002. Eighteen of these sites used a hospital-based model (screeners trained to screen in maternity unit), four the community-based model (health visitors [HVs]) carrying out screening at a home visit), with one site a hybrid model based on specialist HVs carrying out screening in a community setting. The list of participating centres is given in the acknowledgements.
Three sites had a NHSP programme in place before the national implementation of NHSP and were excluded from the present study. The rest of the 20 sites were to provide detailed cost data on NHSP implementation and 14 were invited to provide costs on the IDTS programme, which was being supplanted.
Quantifying resource utilization
A series of questionnaires were devised to collect health resource utilization and family costs. NHSP questionnaires were completed prospectively for over a 12-month period starting from January 2002. Questionnaires on IDTS were retrospectively completed for a 12-month period from 1 May 2000 to 30 April 2001.
Detailed information was sought on staff grade and fulltime equivalent numbers (screeners, local coordinator, team leader, clerical staff); make, model and quantity of screening equipment, consumables, computers and printers; staff travel costs and additional resources (e.g., recruitment, refurbishing rooms). Additionally, training costs were obtained using detailed questionnaires. In order to assess audiology costs, data for 10 consecutive screen referrals and for all true cases were collected.
Family costs were calculated based on the data collected through questionnaires that were distributed to families by local coordinators on invitation.
Costs
Costs were measured in UK prices (£) for February 2003. Standard NHS costs were used where available, and local costs elsewhere. 6, 7 To calculate staff costs, salary midpoint was taken if not specified otherwise. HVs' time for IDTS was estimated at 1%. This estimate was based on an HV screening on average 1.3 children per week and spending approximately 20 min on the screen, which was based on data from the sites.
Information technology (IT) costs and training costs were obtained from NHS salary scales; costs for screening equipment and consumables from the NHS Rehabilitation Services Catalogue, and calibration costs via the Implementation Team.
To determine the non-staff costs, including overheads, building capital and equipment costs associated with running hearing screening services, the following steps were taken: allowances for indirect overheads (the costs of the support services such as human resources, finance and estates required to carry out the services main functions) -taken as fixed cost of £2216, and building capital (the costs assigned to treatment and non-treatment space) relative to the level of pay scale based on Netten et al. 6 Costs associated with lighting, heating and cleaning were assumed to be 11% of the sum of staff costs, indirect overheads and building capital. This was based on previous studies carried out in hospital settings where the direct overheads were found to account for 4-18% (midpoint 11%) of total costs. 8, 9 Average costs of audiological follow-up to confirm falsepositive status were £34.99 for NHSP and £21.33 for IDTS. Average costs of audiological follow-up to confirm hearing loss were £183.64 for NHSP and £168.47 for IDTS. The audiology costs associated with identifying a true case included all the tests and procedures upto hearing aid fitting and consultations by various professionals. Details of method used to calculate audiological cost is provided in the Appendix.
When equipment was totalled over 10 years, a 5% annuity for each year of life was allowed for. Value-added tax (VAT) was charged at 17.5%. The sites provided information of the quantity of consumables they used in November 2002 and prices were obtained from the NHS Purchasing and Supply Agency. VAT was charged at 17.5%.
For NHSP, initial training cost calculation was based on the forms that were filled in during each training session: (i) cost of attending; (ii) cost of conducting the training and (iii) venue costs. (i) and (ii) consist of travel and accommodation costs and cost of time spent by participants and deliverers. Refresher training cost calculation was based on an assumption that refresher training will be 0.5 day a year per screener.
In the case of IDTS, calculations were based on the training pattern (number and duration of sessions, involvement of senior staff etc) provided by the sites.
An average family cost for NHSP, when the screen had not been completed in the maternity unit, was £20.10, consisting of £9.58 in direct costs (travel, car parking, child minding arrangements, etc.) and £10.52 in lost parental wage costs. An average family cost for NHSP follow-up was £36.11 (£20.11 in direct costs and £16.00 in opportunity costs). For IDTS, the average family cost was £20.24 made up by £13.76 worth of direct cost and £6.48 of opportunity costs. Family costing formulae are listed in an Appendix.
Data analysis
Costs are presented per 1000 screened infants for NHSP and IDTS across for each site assuming activity over a 10-year period. Total health-care costs are broken down by set-up costs, screening costs and audiology costs. Costs are reported to the nearest £1.
RESULTS
A total of 16 sites (out of 20, 80%) provided costs on NHSP implementation and 10 (out of 14, 71%) also provided cost information on IDTS, which was being phased out.
Costs of NHSP and IDTS
To illustrate the source and distribution of costs with NHSP and IDTS, the detailed cost data from one of the NHSP sites are shown in Table 1 and Figure 1 for both NHSP and IDTS; over 40% of the total cost is associated with staff costs in running the screen. Initial set-up costs accounted for only 2% of the total NHSP cost. Given the retrospective data collection, a similar figure was not available for IDTS. Families incurred substantially greater costs with IDTS (£111,751; 46% of total IDTS cost) than with NHSP (£59,814; 11% of total NHSP cost).
Variation in NHSP and IDTS costs across sites
The pattern of costs per 1000 infants screened across NHSP and IDTS sites is shown in Tables 2a and 2b. Although the mean health-care cost across NHSP sites (£34,315) was higher than the mean cost across IDTS sites (£25,171), the range of costs across sites varied widely (NHSP: £10,042-£48,074 and IDTS: £15,018-£77,744). Furthermore, the health-care costs of NHSP and IDTS would have been more comparable if set-up costs were available for the IDTS sites. Family costs were on average four-fold higher for IDTS (mean £17,288) than for NHSP (mean £3,732).
Cost per case detected
The health care cost and total cost (including family costs) were expressed relative to the NHSP and IDTS yield. Given the higher yield of NHSP sites, the average cost per case detected across NHSP sites (£31,410/case) was approximately half that of IDTS sites (£69,919/case). Including family costs, the average total cost per case of NHSP (£34,826/case) was almost a quarter of IDTS (£117,942/ case) (Tables 3a and 3b ).
Cost effectiveness of NHSP versus IDTS
The cost-effectiveness is usually expressed as the incremental difference in health-care costs between two alternatives relative to the difference in outcomes achieved by each alternative. 10 In this case, the incremental costeffectiveness is expressed as the difference in the average health-care cost of NHSP compared with IDTS, divided by the difference in average yield between NHSP and IDTS i.e. (£34,315À£25,171)/(1.09À0.36) ¼ £12,527/case detected.
Thus, NHSP would, on average, cost the health service about an extra £12,500 for each additional case detected compared with IDTS. Ignoring the set-up costs for NHSP (which are not taken into account for IDTS), the costeffectiveness of NHSP becomes more attractive at about £11,600 per additional case detected. 
DISCUSSION
The societal cost of implementing NHSP varied considerably across sites. Although the average societal costs of NHSP and IDTS across sites were similar, the family costs associated with NHSP was about one quarter of that for IDTS sites. Furthermore, given the superior yield of NHSP, the cost per A  £503  £24,623  £1258  £26,384  £7568  £33,449  B  £638  £31,271  £1528  £33,437  £1846  £34,645  C  £522  £25,576  £1779  £27,877  £2047  £29,402  D  £730  £35,747  £1079  £37,555  £6542  £43,367  E  £760  £37,218  £806  £38,783  £69,608  £44,984  F  £789  £38,680  £922  £40,391  £763  £40,364  G  £538  £26,357  £1695  £28,590  £6195  £34, 10 It is vital to add that a referral from the NHSP cannot be treated as identical in its benefit to referral from IDTS as there is indirect evidence showing that newborn hearing screen is more effective than the post-neonatal screen, and that there is a high probability that intervention starting in the first six months of life increases the potential for better language and communication. 11, 12 Comparison with other studies Stevens et al. 5 reported that the mean health service costs of NHSP were lower than that of the IDTS, for a standardized district of 1000 live births. Our study indicates that the mean health-care cost per 1000 infants screened with IDTS is lower, just 84% of the mean cost per 1000 babies screened through NHSP. Nevertheless, both studies concur that the cost per case detected by NHSP is superior to that of IDTS. The reasons why the service costs per 1000 live births are higher in NHSP are due mainly to our assumption that HVs spend just 1% of their time for IDTS but also the inclusion of the set-up costs of NHSP that were not calculated in the already long-established IDTS. Moreover, our study was more comprehensive in its cost analysis than Stevens et al., collecting all relevant equipment, consumable and indirect costs. Furthermore, the implementation of NHSP involved comparatively more senior staff.
Several studies have evaluated the cost-effectiveness of NHSP protocols, but only two studies have compared NHSP with other screening strategies, as in this study. 13, 14 The results of these studies appear to be consistent with ours. Kemper et al. estimated the additional health-care costs of NHSP, compared with TNS, would be approximately US$ 24,000 for each additional case detected. 14 Keren et al. 13 also compared NHSP with a selective screening strategy, although they modelled costs over the lifetime of the child. They therefore included not only the costs of screening and diagnostic evaluation but also the costs of medical care, education and assistive devices, and lost productivity over the lifetime of the deaf individual. They estimated an additional health-care cost with NHSP (compared with TNS) of approximately US$44,000 (at 2001 prices) per additional infant whose deafness was diagnosed at six months. Both these cost-effectiveness estimates are similar to those of the present study. The higher cost of Keren et al. is probably because they modelled the imperfect follow-up rate for diagnostic evaluation in the USA. 13 
Strengths and weaknesses of the study
We believe this to be the largest and most detailed cost analysis of infant hearing screening in UK to date. However, some limitations need also to be considered.
The most outstanding limitation of the study was comparing one set of prospective data with a second set of retrospective data. It was due to the fact that once NHSP was introduced, IDTS was in the process of being phased out.
That also made collecting the data very difficult as the motivation to provide figures was appreciably inferior to that of NHSP, in which case costs were notably better documented. Previous studies also reported that it was difficult to obtain data about some stages of post-neonatal screen. 2, 5 This has to be kept in mind when interpreting the costs of NHSP and IDTS.
The number of babies screened by a NHSP site has an impact on the cost of the programme. Sites with higher annual birth population have lower costs of screening per 1000 babies. The same trend has been noted in North America. 15 This has to do with lower set-up and staff costs per baby screened.
Finally, the denominator used in the cost-effectiveness analysis in our study was the number of cases detected, rather than utility associated with earlier identification as well as the disutility of false-positive tests. The collection of such utility data would allow calculation of the cost per quality-adjusted life years (QALYs) of screening; a costeffectiveness metric increasingly being favoured by healthcare policy-makers as they allow resources to be compared and allocated not only across hearing screening programmes but also across other health-care interventions. 16 However, the development of appropriate and sensitive measures for the collection of children's or parent's utility associated with hearing screening remains a subject for future research.
CONCLUSIONS
Results of this study indicate that costs of implementing NHSP are similar to IDTS, although there is wide variation in costs across sites. Family costs and cost per case associated with NHSP are considerably less than IDTS. These findings support the policy of implementation of NHSP and phasing out the IDTS.
